[Pterygium surgery with sutureless, glueless conjunctival graft: Preliminary study at the Centre hospitalier universitaire de Cocody in Abidjan].

Abstract

PURPOSE:

To optimize the pterygium management by delineating the role of sutureless, glueless conjunctival graft.

MATERIALS AND METHODS:

This was a prospective cohort study carried out at the Centre hospitalier universitaire de Cocody between October 1st, 2021 and March 31st, 2022. It analyzed a series of 36 cases of stage I, II and III pterygium by Cornand's classification, who underwent surgery by a sutureless conjunctival graft technique without biological glue.

RESULTS:

Demographically, 33.3% of our study population were between 30 and 40 years of age, with a mean of 47.86 years. The patients showed a female preponderance, 53%, with a male:female ratio of 0.89. At the clinical level, 75% of our population presented for ocular redness, 84% had a nasal pterygium, and 75% were stage 2. In terms of postoperative course and appearance, we observed 80.55% graft stability, 5.56% graft retraction, 2.78% graft displacement, and 11.11% graft loss. At the conclusion of follow-up, we noted an 8.33% recurrence rate.

DISCUSSION:

The use of intraoperative blood ensures patient safety and postoperative comfort. This technique demonstrates satisfactory results with primary, nasal pterygia.

CONCLUSION:

Conjunctival autograft without sutures or biological glue might be a very promising surgical alternative in the surgical treatment of pterygium.

• Authors: A N S Kra, Y G K Ouffoué, R P Agbohoun, M S M P Konan, A C Kouassi-Rebours, M Soumahoro, C E Koman, F X Kouassi
• Journal: Journal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 46 Issue 10 Pg. 1142-1148 (Dec 2023) ISSN: 1773-0597 [Electronic] France
• Vernacular Title: Chirurgie du ptérygion par greffe conjonctivale sans suture ni colle biologique : étude préliminaire au centre hospitalier universitaire de Cocody à Abidjan.
• PMID: 37770319 (Publication Type: English Abstract, Journal Article)
• Copyright: Copyright © 2023 Elsevier Masson SAS. All rights reserved.